Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TDF/FTC add-on for dyslipidemia in virologically suppressed HIV patients on boosted protease inhibitor monotherapy
2011-002853-77Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of tenofovir disoproxil fumarate and emtricitabine in dyslipidemia and Human immunodeficiency virus infection type 1 (2 arms), sponsored by Fight AIDS and Infectious Diseases Foundation. Started Aug 2011; status: completed.
02
Drugs
tenofovir disoproxil fumarateemtricitabine
03
Conditions
dyslipidemiaHuman immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2011-002853-77.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002853-77.